Dose optimisation—the effect of age

International Congress Series

Volumn 1220, Issue C, 2001, Pages 259-271

  Jackson, Stephen H D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Aged; Dose response; Drug combination; Elderly; Frailty; Pharmacodynamics; Pharmacokinetic; Variability

Indexed keywords

EID: 36249011669     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(01)00301-6     Document Type: Article

References (75)

1. Wood, A.J.J, Vestal, R.E, Wilkinson, G.R, Branch, R.A, Shand, D.G, Effect of ageing and cigarette smoking on antipyrine and iodocyanine green elimination. Clin. Pharmacol. Ther. 26 (1979), 16–20.
2. Evans, M.A, Triggs, E.J, Cheung, M, Broe, G.A, Creasey, H, Gastric emptying rate in the elderly: implications for drug therapy. J. Am. Geriatr. Soc. 29 (1981), 201–205.
3. Gainsborough, N, Maskrey, V, Nelson, M, Keating, J, Sherwood, S.H, Swift, C.G, The association of age with gastric emptying. Age Ageing 22 (1993), 37–40.
4. Kupfer, R.M, Heppell, M, Haggith, J.W, Bateman, D.N, Gastric emptying and small bowel transit rate in the elderly. J. Am. Geriatr. Soc. 33 (1985), 340–343.
5. Arora, S, Kassarjian, Z, Krasinski, S.D, Coffey, B, Kaplan, M, Russell, R.M, Effect of age on tests of intestinal and hepatic function in healthy humans. Gastroenterology 96 (1989), 1560–1565.
6. Greenblatt, D.J, Allen, M.D, Locniskar, A, Harmatz, J.S, Shader, R.L, Lorazepam kinetics in the elderly. Clin. Pharmacol. Ther. 26 (1979), 103–113.
7. Ochs, H, Otten, H, Greenblatt, D, Diazepam absorption: effects of age, sex and Billroth gastrectomy. Dig. Dis. Sci. 27 (1982), 225–230.
8. Dreyfuss, D, Shader, R.I, Harmatz, J.S, Greenblatt, D.J, Kinetics and dynamics of single doses of Oxazepam in the elderly: implications of absorption rate. J. Clin. Psychiatry 47 (1986), 511–514.
9. Castleden, C.M, Kaye, C, Parsons, R, The effect of age on plasma levels of Propranadol and Practolol in man. Br. J. Clin. Pharmacol. 2 (1975), 303–306.
10. Cusack, B, Kelly, J, O'Malley, K, Noel, J, Lavan, J, Horgan, J.H, Digoxin in the elderly: pharmacokinetic consequences of old age. Clin. Pharmacol. Ther. 25 (1980), 772–776.
11. Silverio, J, Poole, J.W, Serum concentrations of ampicillin in newborn infants after oral administration. Pediatrics 51 (1973), 578–580.
12. Morselli, P.L, Principi, N, Tognoni, G, Reali, E, Belvedere, G, Standen, S.N, Sereni, F, Diazepam elimination in premature infants and children. J. Perinat. Med. 1 (1973), 133–141.
13. Divoll, M, Ameer, B, Abernethy, D.R, Greenblatt, D.J, Age does not alter acetaminophen absorption. J. Am. Geriatr. Soc. 30 (1982), 240–244.
14. Krauss, J, Desmond, O, Marshall, J, Johnson, R, Schencker, S, Wilkinson, G.R, Effects of ageing and liver disease on disposition of lorazepam. Clin. Pharmacol. Ther. 24 (1978), 411–419.
15. Cusack, B, Kelly, J.G, Lavan, J, Noel, J, O'Malley, K, Theophylline kinetics in relation to age: the importance of smoking. Br. J. Clin. Pharmacol. 10 (1980), 109–114.
16. Oberbauer, R, Krivanek, P, Turnheim, K, Pharmacokinetics and pharmacodynamics of the diuretic bumetanide in the elderly. Clin. Pharmacol. Ther. 57 (1995), 42–51.
17. Roncari, G, Timm, U, Zell, M, Zumbrumen, R, Weber, W, Flumazenil kinetics in the elderly. Eur. J. Clin. Pharmacol. 45 (1993), 585–587.
18. Roila, F, Del Favero, A, Ondansetron clinical pharmacokinetics. Clin. Pharmacokinet. 29 (1995), 95–109.
19. Robertson, D.R.C, Waller, D.G, Renwick, A.G, George, C.F, Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. Br. J. Clin. Pharmacol. 25 (1988), 297–305.
20. Shock, N.W, Watkin, D.M, Yiengst, M.J, Age differences in water content of the body as related to basal oxygen consumption in males. J. Gerontol. 18 (1963), 1–8.
21. Forbes, G.B, Reina, J.C, Adult lean body mass declines with age: some longitudinal observations. Metabolism 19 (1978), 653–663.
22. Vestal, R.E, Mcguire, E.A, Tobin, J.D, Aging and ethanol metabolism. Clin. Pharmacol. Ther. 21 (1977), 343–354.
23. Redolfi, A, Borgogelli, E, Lodola, E, Blood level of cimetidine in relation to age. Eur. J. Clin. Pharmacol., 15, 1979, 257.
24. Wood, A.J.J, Vestal, R.E, Klotz, U, Avant, G, Hoyumpa, A, Schencker, S, Wilkinson, G.R, The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J. Clin. Invest. 55 (1975), 347–359.
25. Nation, R.L, Vine, J, Triggs, E.J, Learoyd, B, Plasma level of chlormethazole and two metabolites after oral administration to young and aged human subjects. Eur. J. Clin. Pharmacol. 12 (1977), 137–145.
26. Jung, D, Mayersohn, M, Perrier, D, Calkins, J, Saunders, R, Thiopental disposition as a function of age in female patients undergoing surgery. Anaesthesiology 56 (1982), 263–268.
27. Nation, R.L, Triggs, E.J, Selig, M, Lignocaine kinetics in cardiac patients and aged subjects. Br. J. Clin. Pharmacol. 4 (1977), 338–439.
28. Cusack, B, O'Malley, K, Laven, J, Nowel, J, Kelly, J.G, Protein binding and disposition of lignocaine in the elderly. Eur. J. Clin. Pharmacol. 29 (1985), 323–329.
29. Rolan, P.E, Plasma protein binding displacement interactions—why are they still regarded as clinically important?. Br. J. Clin. Pharmacol. 37 (1994), 125–128.
30. Kurz, H, Mauser-Ganshorn, A, Stickel, H.H, Differences in the binding of drugs to plasma proteins from newborn and adult man I. Eur. J. Clin. Pharmacol. 11 (1977), 463–467.
31. Campion, E.W, deLabry, L.O, Glynn, R.J, The effect of age on serum albumin in healthy males: report from the Normative Aging Study. J. Gerontol. 43 (1988), 1418–1420.
32. Gunesekera, J, Lee, D.R, Jones, L, Maskrey, V.L, Swift, C.G, Jackson, S.H.D, Does serum albumen fall with increasing age in the absence of disease?. Age Ageing, 25(Suppl. 1), 1996, 29.
33. Greenblatt, D.J, Reduced serum albumen concentration in the elderly: a report from the Boston Collaborative Drug Surveillance Program. J. Am. Geriatr. Soc. 27 (1979), 20–22.
34. Paxton, J.W, Briant, R.H, Alpha 1 acid glycoprotein concentrations and propanalol binding in elderly patients with acute illness. Br. J. Clin. Pharmacol. 18 (1984), 806–810.
35. Verbeeck, R.K, Cardinal, J.A, Wallace, S.M, Effects of age and sex on the plasma binding of acidic and basic drugs. Eur. J. Clin. Pharmacol. 27 (1984), 91–97.
36. Hayes, M.J, Langman, M.J.S, Short, A.H, Changes in drug metabolism with increasing age I: warfarin binding and plasma proteins. Br. J. Clin. Pharmacol. 2 (1975), 73–79.
37. Watkins, P.B, Drug metabolism by cytochromes P450 in the liver and small bowel. Clin. Gastroenterol. Clin. North Am. 21 (1992), 511–526.
38. Sereni, F, Mandelli, M, Principi, N, Tognoni, G, Pardi, G, Morselli, P.L, Induction of drug metabolising enzyme activities in the human fetus and the newborn infant. Enzyme 15 (1973), 318–329.
39. Jalling, B, Boreus, L.O, Rane, A, Sjoqvist, F, Plasma concentrations of diphenylhydantoin in young infants. Pharmacol. Clin. 2 (1970), 200–202.
40. Kinirons, M.T, Morike, K, Shay, S, Roden, D.R, Wood, A.J.J, Does selective inhibition of cytochrome P450s occur?. Clin. Res., 42, 1994, 215A.
41. Vestal, R.E, Wood, A.J.J, Branch, R.A, Shand, D.G, Wilkinson, G.R, Effects of age and smoking on propranolol disposition. Clin. Pharmacol. Ther. 26 (1979), 8–15.
42. Jackson, S.H.D, Johnston, A, Woolard, R, Turner, P, The relationship between theophylline clearance and age in adult life. Eur. J. Clin. Pharmacol. 36 (1989), 29–34.
43. Greenblatt, D.J, Harmatz, J.S, Shader, R.I, Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Clin. Pharmacokinet. 21 (1991), 165–177.
44. Sonne, J, Factors and conditions affecting the glucuronidation of oxazepam. Pharmacol. Toxicol. 73:Suppl. 1 (1993), 1–23.
45. Wynne, H, Yelland, C, Cope, L.H, Boddy, A, Woodhouse, K.W, Bateman, D.N, The association of age and frailty with the pharmacokinetics and pharmacodynamics of metaclopramide. Age Ageing 22 (1993), 354–359.
46. Gachyli, B, Vas, A, Hajos, P, Kalder, A, Acetylator phenotype: effects of age. Eur. J. Clin. Pharmacol., 26, 1984, 43.
47. Feeley, J, Pareira, I, Guy, E, Hockins, N, Factors affecting the response to inhibition of drug metabolism by cimetidine-dose response and sensitivity of elderly and induced subjects. Br. J. Clin. Pharmacol. 17 (1984), 77–81.
48. Swift, C.G, Homeida, M, Halliwell, M, Roberts, C.J.C, Antipyrine disposition and liver size in the elderly. Eur. J. Clin. Pharmacol. 14 (1978), 149–152.
49. Wynne, H, Cope, L.H, Mutch, E, Rawlins, M.D, Woodhouse, K.W, James, O.F.W, The effect of age upon liver volume and apparent LBF in healthy man. Hepatology 9 (1989), 297–301.
50. Vestal, R.E, Wood, A.J.J, Shand, D.G, Reduced β-adrenoreceptor sensitivity in the elderly. Clin. Pharmacol. Ther. 26 (1979), 181–186.
51. Henriksson, P, Svenningsen, N, Kahlmeter, G, Hager, K, Sisomycin treatment of serious neonatal infections. Acta Paediatr. Scand. 66 (1977), 317–322.
52. Davies, D.F, Shock, N.W, Age changes in glomerular filtration rate, effective renal plasma and tubular excretory capacity in adult males. J. Clin. Invest., 29, 1950, 496.
53. Cockroft, T.W, Gault, M.W, Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976), 31–41.
54. Linderman, R.D, Tobin, J, Shock, N.W, longitudinal studies on the rate of decline of renal function with age. J. Am. Geriatr. Soc. 33 (1985), 278–285.
55. Woodhouse, K.W, Wynne, H, Baillie, S, James, O.F.W, Rawlins, M.D, Who are the frail elderly?. Q. J. Med. 68 (1988), 505–506.
56. Williams, F.M, Wynne, H, Woodhouse, K.W, Rawlins, M.D, Plasma aspirin esterase: the influence of old age and frailty. Age Ageing, 1989, 39–42.
57. Shepherd, A.M.M, Hewick, D.S, Moreland, T.A, Stevenson, I.H, Age as a determinant of sensitivity to warfarin. Br. J. Clin. Pharmacol. 4 (1977), 315–320.
58. Reidenberg, M.M, Levy, M, Warner, H, Coutinho, C.B, Shwartz, M.A, Yu, G, Cheiriko, J, Relationship between diazepam dose, plasma level, age and central nervous system depression. Clin. Pharmacol. Ther. 23 (1978), 371–374.
59. Cook, P.J, Flanagan, R, James, I.M, Diazepam tolerance: effect of age, regular sedation, and alcohol. Br. Med. J. 289 (1984), 351–353.
60. Castleden, C.M, George, C.F, Marcer, D, Hallett, C, Increased sensitivity to nitrazepam in old age. Br. Med. J. 1 (1977), 10–12.
61. Messerli, F.H, Grossman, E, Goldbourt, U, Are β blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 279 (1998), 1903–1907.
62. Connolly, M.J, Crowley, J.J, Charan, N.B, Nielson, C.P, Vestal, R.E, Impaired bronchodilator response to albuterol in healthy elderly men and women. Chest 109 (1996), 589–590.
63. Buhler, F.R, Hulthen, U.L, Kiowski, W, Bolli, P, Greater anti-hypertensive efficacy of the calcium channel blocker verapimil in older and lower renin patients. Clin. Sci., 63, 1982, 349.
64. Waddington, J.L, Youssef, H.A, Late onset involuntary movements in chronic schizophrenia: age-related vulnerability to “tardive dyskinesia” independent of extent of neuroleptic medication. Ir. Med. J. 78 (1985), 143–146.
65. Moleman, P, Janzen, G, van Bergen, B.A, Kappers, E.J, Pepplinkhunsen, L, Schmitz, P.I.M, Relationship between age and Parkinsonism in psychiatric patients treated with haloperidol. Am. J. Psychiatry 143 (1986), 232–234.
66. Scott, J.C, Stanski, D.R, Decreased fentanyl and alfentanil dose requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. J. Pharmacol. Exp. Ther. 240 (1987), 159–166.
67. Martin, S.A, Alxiera, S, Carruthers, S.G, The influence of age on dorsal hand vein responsiveness to norepinephrine. Clin. Pharmacol. Ther. 40 (1986), 257–260.
68. Pan, H.Y.M, Hoffman, B.B, Pershe, R.A, Blaschke, T.F, Decline in β-adrenergic receptor mediated vascular relaxation with aging in man. J. Pharmacol. Exp. Ther. 239 (1986), 802–807.
69. Lambert, M.L, Callow, I.D, Feng, Q, Arnold, J.M.O, The effects of age on human venous responsiveness to neuropeptide Y. Br. J. Clin. Pharmacol. 47 (1999), 83–89.
70. Bedarida, G, Bushell, E, Blaschke, T.F, Hoffman, B.B, Differential regulation of H1 and H2 histamine-mediated vasodilation with aging in humans. Clin. Pharmacol. Ther. 58 (1995), 73–90.
71. Ford, G.A, Hoffman, B.B, Vestal, R.E, Blaschke, T.F, Age related changes in adenosine and beta adrenoceptor responsiveness of vascular smooth muscle in man. Br. J. Clin. Pharmacol. 33 (1992), 83–87.
72. Taddei, S, Virdis, A, Mattei, P, Ghiadoni, L, Fasolo, C.B, Sudano, I, Salvetti, A, Hypertension causes premature aging of endothelial function in humans. Hypertension 29 (1997), 736–743.
73. Imaizumi, T, Takeshita, A, Suzuki, S, Yoshida, M, Ando, S, Nakamura, M, Age-dependent forearm vasodilatation by acetylcholine and adenosine 5-triphosphate in humans. Clin. Sci. 78 (1990), 89–93.
74. Lyons, D, Roy, S, Patel, M, Benjamin, N, Swift, C.G, Impaired nitric oxide medicated vasodilation and total body nitric oxide production in healthy old age. Clin. Sci. 93 (1997), 519–525.
75. Andrawis, N, Jones, D.S, Abernethy, D.R, Aging is associated with endothelial dysfunction in the human forearm vasculature. J. Am. Geriatr. Soc. 48 (2000), 193–198.